Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy M Albert

Showing results (291-300 of 342) with videos related to

Pageof 35
Sort By:
American Heart Journal|June 20, 2017
Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registryAdam D DeVore, Laine Thomas, Nancy M Albert, et al.
Circulation. Cardiovascular Quality and Outcomes|July 24, 2024
Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF RegistryRayan S El-Zein, Moghniuddin Mohammed, Daniel D Nguyen, et al.
Circulation. Cardiovascular Quality and Outcomes|April 9, 2018
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) RegistryYevgeniy Khariton, Adrian F Hernandez, Gregg C Fonarow, et al.
JACC. Heart Failure|June 2, 2018
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart FailureYevgeniy Khariton, Michael E Nassif, Laine Thomas, et al.
JACC. Heart Failure|May 11, 2020
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF RegistryMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
The American Journal of Cardiology|November 5, 2019
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)Erika M Giblin, Kirkwood F Adams, Larry Hill, et al.
ESC Heart Failure|May 1, 2021
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fractionMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|July 21, 2018
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF RegistryStephen J Greene, Javed Butler, Nancy M Albert, et al.
Circulation. Heart Failure|January 11, 2024
Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth SubstudyJamie E Diamond, Lisa A Kaltenbach, Bradi B Granger, et al.
JACC. Heart Failure|September 16, 2019
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection FractionYevgeniy Khariton, Gregg C Fonarow, Suzanne V Arnold, et al.
Pageof 35

Showing results (291-300 of 342) with videos related to

Sort By:
Pageof 35
American Heart Journal|June 20, 2017
Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registryAdam D DeVore, Laine Thomas, Nancy M Albert, et al.
Circulation. Cardiovascular Quality and Outcomes|July 24, 2024
Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF RegistryRayan S El-Zein, Moghniuddin Mohammed, Daniel D Nguyen, et al.
Circulation. Cardiovascular Quality and Outcomes|April 9, 2018
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) RegistryYevgeniy Khariton, Adrian F Hernandez, Gregg C Fonarow, et al.
JACC. Heart Failure|June 2, 2018
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart FailureYevgeniy Khariton, Michael E Nassif, Laine Thomas, et al.
JACC. Heart Failure|May 11, 2020
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF RegistryMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
The American Journal of Cardiology|November 5, 2019
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)Erika M Giblin, Kirkwood F Adams, Larry Hill, et al.
ESC Heart Failure|May 1, 2021
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fractionMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|July 21, 2018
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF RegistryStephen J Greene, Javed Butler, Nancy M Albert, et al.
Circulation. Heart Failure|January 11, 2024
Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth SubstudyJamie E Diamond, Lisa A Kaltenbach, Bradi B Granger, et al.
JACC. Heart Failure|September 16, 2019
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection FractionYevgeniy Khariton, Gregg C Fonarow, Suzanne V Arnold, et al.
Pageof 35